Diagnosis and follow up of primary ocular melanoma by radioimmunoscintigraphy

Journal of B.U.ON.

Volumn 9, Issue 3, 2004, Pages 299-302

  Beatović, Slobodanka ^a   Obradovic V ^a   Latkovic Z ^a   Jaksic E ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Anti melanoma antibody; Eye tumor; Immunoscintigraphy; Malignant melanoma; Ruthenium; Tumor imaging

Indexed keywords

MELANOMA ANTIGEN; RUTHENIUM; TECHNETIUM 99M;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER DIAGNOSIS; CHOROID MELANOMA; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EYE TUMOR; FEMALE; FOLLOW UP; HUMAN; IMMUNOSCINTIGRAPHY; MALE; TUMOR VOLUME;

EID: 14944382746     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Scheidhauer K, Scheiffart O, Stefani FH, Markl A, Schumacher V, Moser E. Radioimmunoscintigraphy in cases of primary intraocular malignant melanoma. Proc 4th Symp of Tumor Markers. Hamburg, 1987; 461-470.
2. Bomanji J, Hungerford JL, Granowska M, Britton KE. Radioimmunoscintigraphy of ocular melanoma with 99mTc labeled cutaneous melanoma antibody fragments. Br J Ophthalmol 1987; 71: 651-658.
3. Bomanji J, Garner A, Prasad J. Characterisation of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol 1987; 71: 647-650.
4. Salzillo F, Mele M, Lombardo T, Delle Noci N, Minervini C, D'Addabbo A. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab′)2 in cutaneous and ocular melanomas: cases of particular clinical interest. J Nucl Biol Med 1993; 37: 191-197.
5. Beatovic S, Obradovic V, Latkovic Z, Nastic-Miric D, Davidovic B, Koljevic A. Immunoscintigraphy of primary malignant melanoma of the eye: first experience. Med Pregl 1991; 44(Suppl 1): 99-102 (in Serbian).
6. Scheidler J, Lensinger G, Kirsch CM, Scheiffarth OF, Stefani FH, Ried KG. Immunoimaging of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases. Br J Ophthalmol 1992; 76: 457-460.
7. Sergieva SB, Virtcheva-Genkova A. Radioimmunoscintigraphy in patients with ocular melanoma. Clin Nucl Med 1997; 22: 25-29.
8. Schaling DF, Oosterhuis JA, Jager MJ, Kakebeeke-Kemme H, Pauwels EK. Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma. Br J Ophthalmol 1994; 78: 244-248.
9. Dudczak R, Kletter K, Bailer H, Kokoschka E, Pohl-Markl H. Immunoscintigraphy with a technetium 99m-labelled monoclonal antibody in patients with melanoma. Wiwn Klin Wochenshr 1987; 99: 232-239.
10. Lucignani G, Paganelli G, Modorati G et al. Magnetic resonance imaging, antibody-guided scintigraphy and glucose metabolism in uveal melanoma. J Comput Assist Tomogr 1992; 16: 77-83.
11. Bomanji J, Nimmon CC, Hungerford JL, Solanki K, Granowska M, Britton KE. Ocular radioimmunoscintigraphy: sensitivity and practical considerations. J Nucl Med 1988; 29: 1031-1037.
12. Calbiani B, Bontempelli C, Bonelli P et al. Immunoscintigraphy in the diagnosis of choroid melanoma. Radiol Med 1990; 79(1-2): 92-95.
13. Loffler KU, Brantigam P, Simon J, Althauser SR, Moser E, Witschel H. Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma. Ophtalmologe 1994; 91: 529-532.
14. Loffler KU, Simon JC, Wuttig C, Althauser SR, Brautigam P, Eitschel H. Antigen pattern in choroid melanoma in correlation with immunoscintigraphy. Ophtalmologe 1995; 92: 723-727.
15. Brautigam P, Loeffler KU, Krause T, Hogerle S, Simon J, Moser E. Immunoscintigraphy with anti-225.28S for ocular melanoma; a comparison with histology and immunohistochemistry. Nuklearmedizin 1997; 36: 42-46.
16. Rodot S, Darcourt J, Bussiere F et al. Radiolabelled iodobenzamide for malignant melanoma staging. Melanoma Res 1994; 4: 307-312.